We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
+10.19%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$10.2B
AUM Growth
+$2.04B
(+25%)
Cap. Flow
+$1.34B
Cap. Flow
% of AUM
13.16%
Top 10 Holdings %
Top 10 Hldgs %
16.92%
Holding
1,109
New
201
Increased
523
Reduced
236
Closed
122
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$57.2M |
| 2 |
SCHW
Charles Schwab
SCHW
|
+$52.3M |
| 3 |
Micron Technology
MU
|
+$46M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$45.6M |
| 5 |
Apple
AAPL
|
+$41.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$76.7M |
| 2 |
Bristol-Myers Squibb
BMY
|
+$62.9M |
| 3 |
NVR
NVR
|
+$49.7M |
| 4 |
AZPN
ASPEN TECHNOLOGY INC
AZPN
|
+$37.5M |
| 5 |
DFS
Discover Financial Services
DFS
|
+$35.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.58% |
| 2 | Financials | 15.64% |
| 3 | Healthcare | 14.3% |
| 4 | Consumer Discretionary | 12.01% |
| 5 | Industrials | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
526
Nu Skin
NUS
$250M
| $2.18M | 0.02% |
53,096
+5,406
| +11% | +$221K |
|
527
Murphy Oil
MUR
$5.45B
| $2.16M | 0.02% |
+80,571
| New | +$1.85M |
|
|
AEL
528
DELISTED
American Equity Investment Life Holding Company
AEL
| $2.15M | 0.02% |
71,708
-157,859
| -69% | -$4.28M |
|
529
Western Alliance Bancorporation
WAL
$9.09B
| $2.14M | 0.02% |
37,519
+4,919
| +15% | +$251K |
|
530
Agilysys
AGYS
$3B
| $2.14M | 0.02% |
84,132
+58,232
| +225% | +$1.47M |
|
531
New York Times
NYT
$11.9B
| $2.12M | 0.02% |
+65,759
| New | +$2.04M |
|
|
QVCGA
532
DELISTED
QVC Group Inc Series A
QVCGA
| $2.1M | 0.02% |
+5,127
| New | +$2.31M |
|
|
ASRT
533
DELISTED
Assertio
ASRT
| $2.09M | 0.02% |
27,902
+12,913
| +86% | +$757K |
|
534
Chemours
CC
$2.52B
| $2.09M | 0.02% |
+115,561
| New | +$1.92M |
|
535
SouthState Bank Corp
SSB
$10.2B
| $2.07M | 0.02% |
23,895
+20,015
| +516% | +$1.62M |
|
536
RPM International
RPM
$13.9B
| $2.07M | 0.02% |
26,940
-60
| -0.2% | -$4.35K |
|
537
Invitation Homes
INVH
$17.6B
| $2.04M | 0.02% |
+68,169
| New | +$2.04M |
|
538
American Coastal Insurance
ACIC
$504M
| $2.04M | 0.02% |
161,431
+34,104
| +27% | +$433K |
|
|
TUP
539
DELISTED
Tupperware Brands Corporation
TUP
| $2.02M | 0.02% |
+235,020
| New | +$2.56M |
|
|
TRST
540
Trustco Bank Corp NY
TRST
$977M
| $2.01M | 0.02% |
46,410
+11,312
| +32% | +$484K |
|
|
DRE
541
DELISTED
Duke Realty Corp.
DRE
| $2.01M | 0.02% |
57,901
+1,191
| +2% | +$41.1K |
|
|
VRS
542
DELISTED
Verso Corporation
VRS
| $2.01M | 0.02% |
111,335
+44,671
| +67% | +$717K |
|
|
CNCE
543
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $2M | 0.02% |
216,912
+130,612
| +151% | +$926K |
|
|
Y
544
DELISTED
Alleghany Corp
Y
| $2M | 0.02% |
2,497
-11,596
| -82% | -$9.06M |
|
545
Federal Realty Investment Trust
FRT
$11B
| $1.99M | 0.02% |
15,447
-3,330
| -18% | -$443K |
|
|
PRAH
546
DELISTED
PRA Health Sciences, Inc.
PRAH
| $1.97M | 0.02% |
17,680
-45,457
| -72% | -$4.68M |
|
547
Ooma
OOMA
$564M
| $1.96M | 0.02% |
148,292
+27,100
| +22% | +$330K |
|
|
NPTN
548
DELISTED
NEOPHOTONICS CORP
NPTN
| $1.96M | 0.02% |
221,739
+54,009
| +32% | +$404K |
|
|
FNHC
549
DELISTED
FedNat Holding Company Common Stock
FNHC
| $1.95M | 0.02% |
116,935
+25,323
| +28% | +$378K |
|
550
MarineMax
HZO
$797M
| $1.94M | 0.02% |
+116,214
| New | +$1.89M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q4 2019 Portfolio in Review
As of Q4 2019, Jacobs Levy Equity Management held 1,109 positions worth $10.2B, up 25% from $8.15B the previous quarter. Its ten largest holdings account for 17% of the portfolio.
Jacobs Levy Equity Management deployed $1.34B of net new capital in Q4 2019, opening 201 new positions and adding to 523 existing holdings. Its largest new stake was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Qualcomm, an estimated $76.7M trimmed.
- Jacobs Levy Equity Management's largest Q4 2019 buy was Athene Holding Ltd. Class A Common Shares: 551,505 shares worth $25.9M.
- Jacobs Levy Equity Management added most to AbbVie in Q4 2019, an estimated $57.2M increase.
- Jacobs Levy Equity Management's biggest Q4 2019 reduction was Qualcomm, cutting an estimated $76.7M.
- Jacobs Levy Equity Management fully exited NVR in Q4 2019, selling an estimated $49.7M.
- Jacobs Levy Equity Management's ten largest holdings make up 17% of its $10.2B portfolio in Q4 2019.
- Jacobs Levy Equity Management opened 201 new positions and closed 122 in Q4 2019.
- Jacobs Levy Equity Management's portfolio value rose 25% quarter-over-quarter to $10.2B.
Based on Jacobs Levy Equity Management's 13F filing for Q4 2019, filed 14 Feb 2020.